Table 1

Clinical features and treatment outcome

CaseAge/ sexDuration of DMProgression of MM (months)Weight loss (kg)Involved nervesFunctional limitationsPainTreatmentFollow up (months)PainFunctional status
DM, diabetes mellitus; F, female; IVIG, intravenous immunoglobulin; IVM, intravenous pulse methylprednisolone 500 mg weekly for 12 weeks; L, left; M, male; MM, mononeuritis multiplex; R, right.
147/M4 years1813.6R ulnar, L peroneal, L dorsal ulnar cutaneous, L T8Brace and caneSeverePrednisone24Resolved within one monthNormal: independent walking
255/F4 years1811.4L>R peroneal, L ulnarWheelchairSeverePrednisone, IVIG12No changeNo response: wheelchair
372/F1 year166.8L>R peronealWalkerModerateIVM, chlorambucil6Improved in two monthsImproved: ambulation, cane
461/F3 years16NoneR>L peroneal, L femoralBrace and caneModerateIVM, chlorambucil6Improved in two monthsImproved: ambulation, brace, and cane